Xu-Dong Qu
- Hepatology top 2%
- Surgery
- Oncology
- Molecular Biology
- Cancer Research top 10%
- Topics
- Hepatocellular Carcinoma Treatment and Prognosis (22 papers)Cholangiocarcinoma and Gallbladder Cancer Studies (10 papers)Cancer Research and Treatments (6 papers)
- Cited by
- HepatologyCancer ResearchOncology
In The Last Decade
Xu-Dong Qu
38 papers receiving 835 citations
Hit Papers
Peers
Comparison fields: 5 of 76
- Hepatology 501
- Surgery 240
- Oncology 203
- Molecular Biology 173
- Cancer Research 167
Countries citing papers authored by Xu-Dong Qu
This map shows the geographic impact of Xu-Dong Qu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xu-Dong Qu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xu-Dong Qu more than expected).
Fields of papers citing papers by Xu-Dong Qu
This network shows the impact of papers produced by Xu-Dong Qu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xu-Dong Qu. The network helps show where Xu-Dong Qu may publish in the future.
Co-authorship network of co-authors of Xu-Dong Qu
This figure shows the co-authorship network connecting the top 25 collaborators of Xu-Dong Qu. A scholar is included among the top collaborators of Xu-Dong Qu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xu-Dong Qu. Xu-Dong Qu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 4 | |
| 3 | 7 | |
| 4 | 13 | |
| 5 | 7 | |
| 6 | 32 | |
| 7 | 36 | |
| 8 | 23 | |
| 9 | 80 | |
| 10 | 19 | |
| 11 | 24 | |
| 12 | 13 | |
| 13 | 37 | |
| 14 | 47 | |
| 15 | 16 | |
| 16 | 12 | |
| 17 | 10 | |
| 18 | 79 | |
| 19 | 39 | |
| 20 | 21 |
About Xu-Dong Qu
Xu-Dong Qu is a scholar working on Hepatology, Biotechnology and Cancer Research, having authored 40 papers that have together received 839 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (22 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (10 papers) and Cancer Research and Treatments (6 papers). The work is most often cited by research in Hepatology (501 citations), Cancer Research (167 citations) and Oncology (203 citations). Xu-Dong Qu has collaborated with scholars based in China, Hong Kong and Ethiopia. Frequent co-authors include Rong Liu, Sheng Qian, Jianjun Luo, Jianhua Wang, Zhiping Yan, Jianhua Wang, Guowei Yang, Zhi-Ping Yan, Jia Fan and Ying Jiang. Their work appears in journals such as Journal of Clinical Oncology, Radiology and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.